Radium-223 therapy for metastatic castration-resistant prostate cancer: survival benefit when used earlier in the treatment pathway

Autor: Francis Sundram, Peter Jarvis, Adrian Ho

Publikováno v: Nuclear Medicine Communications. 42:332-336

Background Radium-223 dichloride (Ra-223) therapy improves overall survival in bony metastatic castration-resistant prostate cancer (mCRPC) patients. Recent guidance change recommends Ra-223 following at least two prior therapies for mCRPC. We evalua

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::381cfe6f6e72ec14640393b44417803e
https://doi.org/10.1097/mnm.0000000000001325

Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer

Autor: Caroline Mommsen, Harun Ilhan, Stefano Fanti, Wouter V. Vogel, Francis Sundram, Ignasi Carrió, Yong Du, Giuseppe De Vincentis, Val Lewington, Egbert U. Nitzsche, Wim J.G. Oyen

Publikováno v: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Pompeu Fabra
European Journal of Nuclear Medicine and Molecular Imaging, 44, 10, pp. 1671-1678
European Journal of Nuclear Medicine and Molecular Imaging, 44, 1671-1678
European Journal of Nuclear Medicine and Molecular Imaging

Purpose Radium Ra 223 dichloride (radium-223, Xofigo (R)) is the first targeted alpha therapy for patients with castration-resistant prostate cancer and symptomatic bone metastases. Radium-223 provides a new treatment option for this setting, but als

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a9e26e66757705892fa36f5ceae2be
http://hdl.handle.net/11573/979425

Pharmacological stress myocardial perfusion scintigraphy: use of a modified adenosine protocol in patients with asthma

Autor: Francis Sundram, Neil B. Smith, Alp Notghi

Publikováno v: Nuclear medicine communications. 30(3)

BACKGROUND: Stress radionuclide myocardial perfusion scintigraphy (MPS) using adenosine pharmacological vasodilatation is the preferred method in many centres because of its convenience, safety and speed. It can, however, cause bronchospasm and hence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6aa91ec93f1a35c25048804a1e53f34
https://pubmed.ncbi.nlm.nih.gov/19262284

Response to the paper entitled clinical and therapeutic impact of 18F-FDG PET/CT hole-body acquisition including lower limbs in patients with malignant melanoma

Autor: Francis Sundram, Jennifer Davidson

Publikováno v: Nuclear Medicine Communications. 36:544-545

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d105386eea04ec692544a75c0b6ea386
https://doi.org/10.1097/mnm.0b013e3283450878

British Nuclear Medicine Society Spring Meeting, 22nd - 24th May 2023.

Publikováno v: Nuclear Medicine Communications; Jun2023, Vol. 44 Issue 6, p518-561, 44p